Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Other Non-Current Assets (2009 - 2026)

Evotec SE's (EVO) quarterly Other Non-Current Assets came in at $1.3 million in Q2 2026, up 11.86% year-over-year from $1.1 million in Q2 2025, and up 160.56% quarter-over-quarter from $489371.7 in Q1 2026.

Analysis

Evotec SE (EVO) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Other Non-Current Assets across 9 years of filings, most recently posting $1.3 million for Q2 2026.

  • In Q2 2026, Other Non-Current Assets rose 11.86% year-over-year to $1.3 million; the TTM figure through Jun 2026 stood at $1.3 million (up 11.86% YoY), while the FY2025 annual figure was $572814.3, down 84.72% from the prior year.
  • Other Non-Current Assets came in at $1.3 million for Q2 2026 at Evotec SE, up from $489371.7 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $8.2 million in Q3 2024 to a low of $489371.7 in Q1 2026.
  • Average Other Non-Current Assets over 5 years is $2.7 million, with a median of $1.2 million recorded in 2025.
  • Year-over-year, Other Non-Current Assets surged 488.42% in 2022 and slumped 89.09% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $3.9 million in 2022, then slumped by 76.68% to $900561.7 in 2023, then jumped by 311.03% to $3.7 million in 2024, then sank by 84.06% to $590170.1 in 2025, then jumped by 116.06% to $1.3 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.3 million in Q2 2026, $489371.7 in Q1 2026, and $590170.1 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn 558.00 Mn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 25.20 Mn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 587.56 Mn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn 117.41 Mn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn 91.80 Mn
6 Evotec SE 642.83 Mn 216.96 Mn - 1.28 Mn
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn 87.48 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 212,000.00
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 91,917.76
10 VivoSim Labs 1.45 Mn 1.45 Mn - 143,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.28 Mn
Mar 31, 2026 489,371.68
Dec 31, 2025 590,170.06
Sep 30, 2025 889,650.92
Jun 30, 2025 1.14 Mn
Mar 31, 2025 3.11 Mn
Dec 31, 2024 3.70 Mn
Sep 30, 2024 8.15 Mn
Mar 31, 2024 924,493.86
Dec 31, 2023 900,561.70
Dec 31, 2022 3.86 Mn
Sep 30, 2022 5.89 Mn
Jun 30, 2022 5.45 Mn
Mar 31, 2022 969,699.79
Dec 31, 2021 995,254.73
Sep 30, 2021 1.00 Mn
Dec 31, 2020 1.06 Mn
Sep 30, 2010 3.98 Mn
Jun 30, 2010 3.94 Mn
Mar 31, 2010 5,038.96